PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 16 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,348,000 | -6.9% | 2,806,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,521,000 | +6.8% | 2,806,000 | +2.0% | 0.00% | 0.0% |
| Q1 2021 | $2,360,000 | -29.2% | 2,750,000 | -31.2% | 0.00% | 0.0% |
| Q4 2020 | $3,331,000 | +3.7% | 4,000,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,213,000 | +0.9% | 4,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $3,184,000 | +10.9% | 4,000,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,872,000 | +114.0% | 4,000,000 | +100.0% | 0.00% | – |
| Q4 2019 | $1,342,000 | – | 2,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cohanzick Management, LLC | 25,112,000 | $25,557,982 | 22.10% |
| Westchester Capital Management, LLC | 8,267,000 | $8,308,536 | 0.24% |
| MACQUARIE GROUP LTD | 5,359,000 | $5,386,000 | 0.01% |